<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="table4-1759720X20912646" orientation="portrait" position="float">
 <label>Table 4.</label>
 <caption>
  <p>Risk of HBVr stratified per HBV status and agent used.</p>
 </caption>
 <alternatives>
  <graphic xlink:href="10.1177_1759720X20912646-table4" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" span="1"/>
    <col align="char" char="." span="1"/>
    <col align="char" char="." span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Medication</th>
     <th align="left" rowspan="1" colspan="1">Chronic HBV infection
      <break/>[HBsAg (+)]
     </th>
     <th align="left" rowspan="1" colspan="1">Resolved HBV infection
      <break/>[HBsAg (−) / anti-HBc (+)]
     </th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td colspan="3" rowspan="1">GCs</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">GC &gt;20 mg/day and &gt;4 weeks</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td colspan="3" rowspan="1">Nonbiologics</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">MTX, AZA, MMF, LEF, HCQ</td>
     <td rowspan="1" colspan="1">Low</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">CYC</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td colspan="3" rowspan="1">Biologics</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">TNFi</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">RTX</td>
     <td rowspan="1" colspan="1">Very high</td>
     <td rowspan="1" colspan="1">Moderate</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">ABA</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">IL-6 inhibitors</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">IL-17 inhibitors</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">IL-12/23 inhibitors</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
    <tr>
     <td colspan="3" rowspan="1">Oral targeted therapies</td>
    </tr>
    <tr>
     <td rowspan="1" colspan="1">JAK inhibitors</td>
     <td rowspan="1" colspan="1">Moderate</td>
     <td rowspan="1" colspan="1">Low</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="table-fn6-1759720X20912646">
   <p>ABA, Abatacept ; anti-HBc, antibody against Hepatitis B core antigen; AZA, azathioprine; CYC, Cyclophosphamide; GC, glucocorticoids; HBsAg, Hepatitis B surface antigen; HCQ, hydroxychloroquine; IL, interleukin; JAK, Janus kinase; LEF, leflunomide; MMF, mycophenolate mofetil; MTX, methotrexate; RTX, Rituximab ; TNFi, tumor necrosis factor inhibitors.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
